Michele Ravara appointed as General Manager of AbbVie Switzerland

“As the newly appointed Managing Director of AbbVie Switzerland, I am honored to lead our efforts in fostering strategic partnerships with all the stakeholders within Switzerland’s healthcare system”, says Michele Ravara. ”Together with my colleagues on the management team, and the 280 employees of AbbVie Switzerland, I am committed to ensuring that Switzerland remains at the forefront of healthcare innovation. Our unwavering priority is to ensure that all patients in need benefit from our transformative therapies, gaining timely, equitable, and appropriate access to them.”

Michele is a Global Executive with over 25 years of experience. His career has spanned the entire pharma value chain, encompassing roles in Country Operations - such as General Management and Head of Access in Italy as well as Global positions in Development, Strategy, Marketing, and Commercial Operations. Michele joined AbbVie in October 2020 as General Manager of Oncology within Global Marketing and Commercial Operations. He holds a degree in electrical engineering and mathematics from the Università di Pavia in Italy and has a humanistic background.

About AbbVie
We are a global, research-based biopharmaceutical company focused on the discovery and development of innovative treatments that address some of the world’s most serious and complex diseases. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care and virology. In addition, AbbVie offers products and services through its Allergan Aesthetics portfolio. Patients in more than 175 countries benefit from AbbVie medications.

AbbVie, with headquarters in Chicago, USA, employs over 55,000 employees worldwide. Approximately 280 employees are employed in Switzerland and the AbbVie Switzerland headquarters are in Cham, ZG.